A Comparison of the Costs and Efficacy of Ondansetron and Dolasetron in the Prophylaxis of Postoperative Vomiting in Pediatric Patients Undergoing Ambulatory Surgery
Anesth Analg 2003 97: 390-396.
[Abstract]
[Full Text]
IMPLICATIONS: This randomized double-blinded dose-ranging study concluded that dolasetron, 350 {micro}g/kg IV, was the smallest dose that provided acceptable equivalent efficacy and patient satisfaction scores to ondansetron, 100 {micro}g/kg IV, for the prophylaxis of postoperative vomiting in children undergoing outpatient surgery. However, with this dose, the costs to the institution for managing postoperative vomiting were less.